These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29190549)

  • 1. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
    Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
    J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis.
    Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Mateo-Gallego R; Bea AM; Perez-Calahorra S; Marco-Benedi V; Civeira F
    J Steroid Biochem Mol Biol; 2017 May; 169():226-233. PubMed ID: 27769814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
    García-Otín AL; Cofán M; Junyent M; Recalde D; Cenarro A; Pocoví M; Ros E; Civeira F
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3667-73. PubMed ID: 17566095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
    Baila-Rueda L; Mateo-Gallego R; Jarauta E; de Castro-Orós I; Bea AM; Cenarro A; Civeira F
    Biochem Biophys Res Commun; 2014 Apr; 446(3):731-5. PubMed ID: 24406166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols.
    Lamiquiz-Moneo I; Baila-Rueda L; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Marco-Benedí V; Martín-Navarro A; Ros E; Cofán M; Rodríguez-Rey JC; Pocovi M; Cenarro A; Civeira F
    J Clin Lipidol; 2017; 11(6):1432-1440.e4. PubMed ID: 29066094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cholesterol sterols in different forms of primary hyperlipemias.
    Lupattelli G; Pirro M; Siepi D; Mannarino MR; Roscini AR; Vaudo G; Pasqualini L; Schillaci G; Mannarino E
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):231-6. PubMed ID: 20708389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia.
    Mateo-Gallego R; Perez-Calahorra S; Cofán M; Baila-Rueda L; Cenarro A; Ros E; Puzo J; Civeira F
    J Nutr; 2014 Aug; 144(8):1219-26. PubMed ID: 24899155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.
    Pei WD; Sun YH; Lu B; Liu Q; Zhang CY; Zhang J; Jia YH; Lu ZL; Hui RT; Liu LS; Yang YJ
    Int J Cardiol; 2007 Mar; 116(2):194-200. PubMed ID: 16828905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.
    Baila-Rueda L; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Mateo-Gallego R; Lamiquiz-Moneo I; de Castro-Orós I; Cenarro A; Civeira F
    Atherosclerosis; 2016 Mar; 246():202-7. PubMed ID: 26802983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
    Noto D; Cefalù AB; Barraco G; Martino E; Fayer F; Minà M; Montali A; Arca M; Averna M; Martino F
    Pediatr Res; 2010 Feb; 67(2):200-4. PubMed ID: 20091938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia].
    Pei WD; Sun YH; Rou WJ; Zu Q; Li Y; Zhang CY; Dai J; Jia YH; Lu ZL; Wu XG; Liu LS; Hui RT
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):313-7. PubMed ID: 15854507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
    Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
    IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The hypercholesterolemias in pregnancy: their etiology and diagnostic significance considerations].
    Hyánek J; Pehal F; Dubská L; Miková J; Gombíková L; Kubů S; Haláčková P; Feyereisl J; Táborský L
    Ceska Gynekol; 2017; 82(6):455-461. PubMed ID: 29302979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas Chromatography and Flame-Ionization Detection of Non-Cholesterol Sterols as Indicators of Cholesterol Absorption and Synthesis in 158 Chinese Individuals with Normolipidemia, Hyperlipidemia, and Familial Hypercholesterolemia.
    Li ZZ; Wang QH; Liu Y; Wang L; Yu ZQ; Huang Q; Zhang J
    Med Sci Monit; 2022 Feb; 28():e934471. PubMed ID: 35152260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.